COVIDMED – An early pandemic randomized clinical trial of losartan treatment for hospitalized COVID-19 patients

OBJECTIVES: To assess the efficacy and safety of losartan for COVID-19 patients. METHODS: COVIDMED was a double-blinded, placebo-controlled platform RCT. Enrollees were randomized to standard care plus hydroxychloroquine, lopinavir/ritonavir, losartan, or placebo. Hydroxychloroquine and lopinavir/ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Freilich, Daniel, Victory, Jennifer, Jenkins, Paul, Gadomski, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296371/
https://www.ncbi.nlm.nih.gov/pubmed/35874909
http://dx.doi.org/10.1016/j.conctc.2022.100968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296371/
https://www.ncbi.nlm.nih.gov/pubmed/35874909
http://dx.doi.org/10.1016/j.conctc.2022.100968

Ejemplares similares